{"id":24383,"date":"2024-05-24T11:48:14","date_gmt":"2024-05-24T15:48:14","guid":{"rendered":"https:\/\/www.mesotheliomahope.com\/?p=24383"},"modified":"2024-05-28T09:05:21","modified_gmt":"2024-05-28T13:05:21","slug":"new-study-shows-novel-drug-roginolisib-can-help-disrupt-mesothelioma-cancer-growth","status":"publish","type":"post","link":"https:\/\/www.mesotheliomahope.com\/blog\/new-study-shows-novel-drug-roginolisib-can-help-disrupt-mesothelioma-cancer-growth\/","title":{"rendered":"New Study Shows Novel Drug Roginolisib Can Help Disrupt Mesothelioma Cancer Growth"},"content":{"rendered":"<p>For the first time, a new study has provided evidence that supports the use of the novel drug roginolisib (also known as IOA-244) in combination with other treatments for <a href=\"\/mesothelioma\/\">mesothelioma<\/a>.<\/p>\n<p>The study, published in the May 2024 issue of <em>Translational Oncology<\/em>, found that roginolisib is effective at stopping mesothelioma growth and strengthening the immune system.<\/p>\n<p>Learn more about the study results and how roginolisib works to fight mesothelioma.<\/p>\n<h2>What Is Roginolisib, and How Does It Work?<\/h2>\n<p>Roginolisib is an oral medication that targets PI3K-\u03b4. PI3K-\u03b4 (phosphoinositide 3-kinase delta) is a protein found in the body\u2019s cells. In some cancers, like <a href=\"\/mesothelioma\/pleural\/\">pleural mesothelioma<\/a> (which affects the lung lining), there is too much of PI3K-\u03b4.<\/p>\n<p>PI3K-\u03b4 helps mesothelioma cancer spread by making cancer cells grow faster, survive longer, and move more easily to other parts of the body. Because of this, patients with high PI3K-\u03b4 expression often have a shorter life expectancy.<\/p>\n<blockquote><p>Mesothelioma patients with high PI3K-\u03b4 expression have an average <a href=\"\/mesothelioma\/prognosis\/life-expectancy\/\">life expectancy<\/a> of 12 months compared to 25 months for patients with low PI3K-\u03b4 expression.<\/p><\/blockquote>\n<p><strong>The study team found that roginolisib:<\/strong><\/p>\n<ul>\n<li>Blocks PI3K-\u03b4 to stop mesothelioma cells from growing and spreading<\/li>\n<li>Helps the immune system better fight cancer<\/li>\n<li>Makes <a href=\"\/treatment\/\">mesothelioma treatment<\/a> more effective by attacking the cancer from multiple angles<\/li>\n<\/ul>\n<p>Use our <strong>Free Doctor Match service<\/strong> to find mesothelioma specialists in your area who can determine the best treatments to improve your life expectancy.<\/p>\n<h2>Study Highlights: Can Roginolisib Help Manage Mesothelioma?<\/h2>\n<p>Roginolisib is a promising new therapy for mesothelioma, especially for patients who haven\u2019t seen success with traditional treatments.<\/p>\n<p><strong>The researchers who conducted the study found that roginolisib:<\/strong><\/p>\n<ul>\n<li><strong>Induces cancer cell death.<\/strong> Roginolisib was found to induce apoptosis, a process that leads to cancer cell death. This is a crucial step in stopping the spread of mesothelioma.<\/li>\n<li><strong>Boosts immune response.<\/strong> The drug also enhances the body&#8217;s immune response against cancer. It increases the number of immune cells that attack mesothelioma cells while reducing those that suppress the immune system.<\/li>\n<li><strong>Works well with other treatments.<\/strong> When used in combination with other treatments like the immunotherapy drug <a href=\"\/treatment\/immunotherapy\/opdivo-yervoy\/\">nivolumab (Opdivo\u00ae)<\/a> and cisplatin (a chemotherapy drug), roginolisib showed better results than when any of these treatments were used alone.<\/li>\n<\/ul>\n<p>While high doses of roginolisib were most effective, the study noted that lower, sustained doses could also be beneficial for patients, especially when combined with other mesothelioma treatments like chemotherapy and <a href=\"\/treatment\/immunotherapy\/\">immunotherapy<\/a>.<\/p>\n<p>Interested in immunotherapy for mesothelioma? Download ou<strong>r Free Immunotherapy Guide<\/strong> to learn how it works and what to expect during treatment.<\/p>\n<div id=\"23756\" class=\"one-off-23756 widget widget_oscar-vque one-off\" data-vqueid=\"23756\"><style type=\"text\/css\" data-style=\"one-off\">.one-off-23756{margin:60px auto}.one-off-23756 a{box-shadow:0 4px 4px 0 rgba(0,0,0,.25);display:block;background:linear-gradient(90deg,#B1E5EA 0,#0FAEBF 100%);padding:20px;text-decoration:none;color:inherit;position:relative;overflow:hidden;max-width:350px;margin:0 auto}.one-off-23756 a::before{background:#EDF8F9;border-radius:0 0 50% 50%;content:'';position:absolute;top:0;height:87%;width:140%;left:-70px;z-index:0}.one-off-23756 .vque-content,.one-off-23756 .image-wrap{z-index:1;position:relative}.one-off-23756 .image-wrap{max-width:163px;display:block;margin:15px auto -21px}.one-off-23756 .heading{font-size:24px;line-height:28px;text-align:center;display:block;max-width:340px;margin:5px auto 25px}.one-off-23756 ul{max-width:160px;list-style:none;margin:-10px auto 22px;text-align:left;font-size:16px;line-height:27px}.one-off-23756 ul li{margin:0;position:relative;padding-left:28px}.one-off-23756 ul li::before{font-family:\"mesohope\"!important;speak:none;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;line-height:1;content:\"\\e904\";background:#0FAEBF;width:14px;height:14px;display:block;position:absolute;left:0;top:7px;border-radius:50%;color:#fff;font-size:7px;text-align:center;line-height:14px}.one-off-23756 p{text-align:center}.one-off-23756 .button{padding:12px 16px}@media screen and (min-width:768px){.one-off-23756 a{max-width:620px;padding:25px 50px 29px;border-radius:0 0 4px 4px}.one-off-23756 a::before{border-radius:0 0 100% 0;height:83%;width:70%;right:-70px;left:unset}.one-off-23756 a::after{background:#EDF8F9;border-radius:0;content:'';position:absolute;top:0;height:82%;width:50%;left:0;z-index:0}.one-off-23756 .heading{text-align:left;margin:5px 0 25px}.one-off-23756 ul{margin:-10px 0 22px}.one-off-23756 .image-wrap{max-width:unset;position:absolute;right:0;bottom:0;margin:0 0 -2px}.one-off-23756 p{text-align:left}}<\/style><a href=\"\/immunotherapy-guide\/\" title=\"Get Your Free Immunotherapy Guide\" class=\"cte\" data-ce-category=\"In-Content Ads\" data-ce-label=\"Get Your Free Immunotherapy Guide Ad\"><div>\r\n    <div class=\"vque-content\">\r\n        <strong class=\"heading\">Get Your Free Immunotherapy Guide<\/strong>\r\n        <ul>\r\n            <li>When it\u2019s used<\/li>\r\n            <li>Types of drugs<\/li>\r\n            <li>Side effects<\/li>\r\n        <\/ul>\r\n        <p><strong class=\"button arrow\" title=\"Get Your Free Guide\">Get Your Free Guide<\/strong><\/p>\r\n    <\/div>\r\n    <div class=\"image-wrap\"><img decoding=\"async\"  src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" data-src=\"\/wp-content\/uploads\/2024\/03\/download-immunotherapy-guide.png\" alt=\"Free Immunotherapy Guide\" class=\"lazyload\" ><\/div>\r\n<\/div><\/a><\/div>\n<h2>What the Study Results Mean for Mesothelioma Patients<\/h2>\n<p>The 89 pleural mesothelioma patients who participated in the study experienced positive effects from taking roginolisib by itself and combined with other treatments.<\/p>\n<p><strong>Here are some key takeaways:<\/strong><\/p>\n<ul>\n<li>Combining roginolisib with other cancer-fighting drugs like <a href=\"\/treatment\/immunotherapy\/checkpoint-inhibitors\/\">immune checkpoint inhibitors<\/a> and cisplatin could offer a more effective treatment regimen, providing improved survival outcomes.<\/li>\n<li>Because roginolisib selectively targets the PI3K\u03b4 enzyme without affecting healthy cells, it may cause fewer side effects compared to traditional <a href=\"\/treatment\/chemotherapy\/\">chemotherapy<\/a>.<\/li>\n<li>The ability of roginolisib to induce cancer cell death and boost the body&#8217;s immune response could lead to longer survival times for patients.<\/li>\n<\/ul>\n<h2>We Can Help You Get Treatment for Mesothelioma<\/h2>\n<p>If you\u2019re interested in new and emerging treatments like roginolisib, our team can connect you with an experienced <a href=\"\/treatment\/doctors\/\">mesothelioma specialist<\/a>.<\/p>\n<p><strong>The right mesothelioma specialist can help you:<\/strong><\/p>\n<ul>\n<li>Confirm your diagnosis and <a href=\"\/mesothelioma\/stages\/\">cancer stage<\/a><\/li>\n<li>Determine your treatment options<\/li>\n<li>Enroll in new mesothelioma drug trials<\/li>\n<li>Understand your <a href=\"\/mesothelioma\/prognosis\/\">prognosis<\/a> (health outlook)<\/li>\n<\/ul>\n<p>Our Patient Advocates have relationships with top doctors across the country and can help you find the best specialist to treat your cancer.<\/p>\n<p>Give us a call at <a href=\"tel:+18666088933\" title=\"Click to call (866) 608-8933\" class=\"in-content-tel-link\" data-ce-category=\"Click to Call\" data-ce-label=\"(866) 608-8933\">(866) 608-8933<\/a> or use our <a href=\"\/get-matched\/\">Free Doctor Match<\/a> now to find mesothelioma specialists near you.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>For the first time, a new study has provided evidence that supports the use of the novel drug roginolisib (also known as IOA-244) in combination with other treatments for mesothelioma. The study, published in the May 2024 issue of Translational Oncology, found that roginolisib is effective at stopping mesothelioma growth and strengthening the immune system.&hellip;<\/p>\n","protected":false},"author":35,"featured_media":24354,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[118],"tags":[],"class_list":["post-24383","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mesothelioma-treatment"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/posts\/24383","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/comments?post=24383"}],"version-history":[{"count":0,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/posts\/24383\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/media\/24354"}],"wp:attachment":[{"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/media?parent=24383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/categories?post=24383"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/tags?post=24383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}